Belpointe Asset Management’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-100
Closed -$1.67K 3296
2023
Q1
$1.67K Buy
+100
New +$1.67K ﹤0.01% 3360